BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201208T160000
DTEND;TZID=America/Vancouver:20201208T170000
DTSTAMP:20260812T012800
CREATED:20201123T221032Z
LAST-MODIFIED:20201123T221032Z
UID:11826-1607443200-1607446800@scienceinboston.com
SUMMARY:MIT Biology Colloquium Series: Dr. Paul Turner
DESCRIPTION:Speaker: Dr. Paul Turner\, Yale University School of Medicine. Title: “Leveraging evolutionary trade-offs and phage selection pressure to reduce bacterial pathogenicity”.  Hosted by Sebastian Lourido. The Biology Colloquium is a weekly seminar held throughout the academic year\, featuring distinguished speakers in many areas of the biological sciences\, from universities and institutions worldwide. More information on speakers\, their affiliations\, and titles of their talks will be added as available. The Colloquium will zoom at 4:00PM  Tuesdays during the school year. Contact: Linda Earle lkn@mit.edu
URL:https://scienceinboston.com/event/mit-biology-colloquium-series-dr-paul-turner/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201208T160000
DTEND;TZID=America/Vancouver:20201208T170000
DTSTAMP:20260812T012800
CREATED:20201123T221032Z
LAST-MODIFIED:20201123T221032Z
UID:27613-1607443200-1607446800@scienceinboston.com
SUMMARY:MIT Biology Colloquium Series: Dr. Paul Turner
DESCRIPTION:Speaker: Dr. Paul Turner\, Yale University School of Medicine. Title: “Leveraging evolutionary trade-offs and phage selection pressure to reduce bacterial pathogenicity”.  Hosted by Sebastian Lourido. The Biology Colloquium is a weekly seminar held throughout the academic year\, featuring distinguished speakers in many areas of the biological sciences\, from universities and institutions worldwide. More information on speakers\, their affiliations\, and titles of their talks will be added as available. The Colloquium will zoom at 4:00PM  Tuesdays during the school year. Contact: Linda Earle lkn@mit.edu
URL:https://scienceinboston.com/event/mit-biology-colloquium-series-dr-paul-turner-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201208T100000
DTEND;TZID=America/Vancouver:20201208T110000
DTSTAMP:20260812T012800
CREATED:20201202T214638Z
LAST-MODIFIED:20201202T214638Z
UID:11980-1607421600-1607425200@scienceinboston.com
SUMMARY:BioPharma Manufacturing In Massachusetts: A Talent Powerhouse Continues To Fuel Growth
DESCRIPTION:Massachusetts has long been the epicenter of biopharma research and development. Years of investment and collaboration between industry\, academia\, and government has provided biopharma manufacturers a rich and deep talent landscape in Massachusetts. Join leaders in the biopharma industry and higher education as they discuss current talent development assets\, share initiatives to grow talent even further\, and look to the future as the industry continues its growth in Massachusetts. \nThis virtual Forum\, hosted in partnership by MassBio\, MassECON\, MassBioEd\, and the Massachusetts Life Sciences Center\, will include an overview of current biopharma talent assets and how the pool of talent has grown in recent years\, followed by an industry-higher education panel that will share case studies on collaboration and insights on what is on the horizon for new talent development.\nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/biopharma-manufacturing-in-massachusetts-a-talent-powerhouse-continues-to-fuel-growth/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201208T100000
DTEND;TZID=America/Vancouver:20201208T110000
DTSTAMP:20260812T012800
CREATED:20201202T214638Z
LAST-MODIFIED:20201202T214638Z
UID:27619-1607421600-1607425200@scienceinboston.com
SUMMARY:BioPharma Manufacturing In Massachusetts: A Talent Powerhouse Continues To Fuel Growth
DESCRIPTION:Massachusetts has long been the epicenter of biopharma research and development. Years of investment and collaboration between industry\, academia\, and government has provided biopharma manufacturers a rich and deep talent landscape in Massachusetts. Join leaders in the biopharma industry and higher education as they discuss current talent development assets\, share initiatives to grow talent even further\, and look to the future as the industry continues its growth in Massachusetts. \nThis virtual Forum\, hosted in partnership by MassBio\, MassECON\, MassBioEd\, and the Massachusetts Life Sciences Center\, will include an overview of current biopharma talent assets and how the pool of talent has grown in recent years\, followed by an industry-higher education panel that will share case studies on collaboration and insights on what is on the horizon for new talent development.\nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/biopharma-manufacturing-in-massachusetts-a-talent-powerhouse-continues-to-fuel-growth-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201207T120000
DTEND;TZID=America/Vancouver:20201207T130000
DTSTAMP:20260812T012800
CREATED:20201123T220236Z
LAST-MODIFIED:20201123T220236Z
UID:11820-1607342400-1607346000@scienceinboston.com
SUMMARY:Research Connection LIVE: Virtual Edition
DESCRIPTION:Introduction to Dr. Ursula Kaiser the new Director of the Brigham Research Institute
URL:https://scienceinboston.com/event/research-connection-live-virtual-edition/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201207T120000
DTEND;TZID=America/Vancouver:20201207T130000
DTSTAMP:20260812T012800
CREATED:20201123T220236Z
LAST-MODIFIED:20201123T220236Z
UID:27611-1607342400-1607346000@scienceinboston.com
SUMMARY:Research Connection LIVE: Virtual Edition
DESCRIPTION:Introduction to Dr. Ursula Kaiser the new Director of the Brigham Research Institute
URL:https://scienceinboston.com/event/research-connection-live-virtual-edition-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201204T140000
DTEND;TZID=America/Vancouver:20201204T150000
DTSTAMP:20260812T012800
CREATED:20201123T221258Z
LAST-MODIFIED:20201123T221258Z
UID:11829-1607090400-1607094000@scienceinboston.com
SUMMARY:The History of Now: Plagues and Pandemics Series
DESCRIPTION:
URL:https://scienceinboston.com/event/the-history-of-now-plagues-and-pandemics-series/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/SHASS_21H.000-poster-scaled-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201204T140000
DTEND;TZID=America/Vancouver:20201204T150000
DTSTAMP:20260812T012800
CREATED:20201123T221258Z
LAST-MODIFIED:20201123T221258Z
UID:27614-1607090400-1607094000@scienceinboston.com
SUMMARY:The History of Now: Plagues and Pandemics Series
DESCRIPTION:
URL:https://scienceinboston.com/event/the-history-of-now-plagues-and-pandemics-series-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/SHASS_21H.000-poster-scaled-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201203T120000
DTEND;TZID=America/Vancouver:20201203T130000
DTSTAMP:20260812T012800
CREATED:20201123T215001Z
LAST-MODIFIED:20201123T215001Z
UID:11811-1606996800-1607000400@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar
DESCRIPTION:Small-molecule-induced protein polymerization\n\nMikolaj Slabicki\, Hojong Yoon\, Jonas Koeppel \nDecember 3rd\, 2020  \nWebinar registration: \nhttps://dfci.zoom.us/webinar/register/WN_rOAQV4c8Tge2bXW23l9rYQ \nHost: Katherine Donovan \n\n\nResearchers from the Ebert and Fischer lab teamed up to solve the elusive mechanism of a BCL6 degrader\, BI-3802. By employing functional screens\, biochemical dissection\, and structural characterization\, they identified that BI-3802 induces BCL6 polymerization\, which triggers proteasomal degradation of BCL6. The seminar will be presented by Mikolaj Slabicki (Ebert Lab)\, Hojong Yoon (Fischer Lab)\, and Jonas Koeppel (Ebert Lab).
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201203T120000
DTEND;TZID=America/Vancouver:20201203T130000
DTSTAMP:20260812T012800
CREATED:20201123T215001Z
LAST-MODIFIED:20201123T215001Z
UID:27608-1606996800-1607000400@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar
DESCRIPTION:Small-molecule-induced protein polymerization\n\nMikolaj Slabicki\, Hojong Yoon\, Jonas Koeppel \nDecember 3rd\, 2020  \nWebinar registration: \nhttps://dfci.zoom.us/webinar/register/WN_rOAQV4c8Tge2bXW23l9rYQ \nHost: Katherine Donovan \n\n\nResearchers from the Ebert and Fischer lab teamed up to solve the elusive mechanism of a BCL6 degrader\, BI-3802. By employing functional screens\, biochemical dissection\, and structural characterization\, they identified that BI-3802 induces BCL6 polymerization\, which triggers proteasomal degradation of BCL6. The seminar will be presented by Mikolaj Slabicki (Ebert Lab)\, Hojong Yoon (Fischer Lab)\, and Jonas Koeppel (Ebert Lab).
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T183000
DTEND;TZID=America/Vancouver:20201202T203000
DTSTAMP:20260812T012800
CREATED:20201123T221933Z
LAST-MODIFIED:20201123T221933Z
UID:11838-1606933800-1606941000@scienceinboston.com
SUMMARY:Hit Me with Your Best Shot: Vaccines and COVID-19
DESCRIPTION:With an estimated 35 million infected and over 1 million deaths\, SARS-CoV-2 has ravaged the world. We are waiting for scientists to produce a life-saving vaccine that can prevent the serious illness COVID-19 and help bring this pandemic to an end. Currently\, there are nearly 200 different vaccines in various stages of development. How does SARS-CoV-2 cause disease\, and how do vaccines work to prevent us from getting sick? How are scientists and manufacturers working together to safely speed up the vaccine development process which typically takes years? In this lecture\, we will discuss how we can enable the immune system to fight serious infection. \nTime: 6:30-8:30 p.m.\, Wednesday\, December 2nd \nJoin us on: Zoom (password: Seminar) or YouTube Live \nSpeaker: Aly Warr \nGraphics: Iryna Stryapunina
URL:https://scienceinboston.com/event/hit-me-with-your-best-shot-vaccines-and-covid-19/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/COVID-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T183000
DTEND;TZID=America/Vancouver:20201202T203000
DTSTAMP:20260812T012800
CREATED:20201123T221933Z
LAST-MODIFIED:20201123T221933Z
UID:27616-1606933800-1606941000@scienceinboston.com
SUMMARY:Hit Me with Your Best Shot: Vaccines and COVID-19
DESCRIPTION:With an estimated 35 million infected and over 1 million deaths\, SARS-CoV-2 has ravaged the world. We are waiting for scientists to produce a life-saving vaccine that can prevent the serious illness COVID-19 and help bring this pandemic to an end. Currently\, there are nearly 200 different vaccines in various stages of development. How does SARS-CoV-2 cause disease\, and how do vaccines work to prevent us from getting sick? How are scientists and manufacturers working together to safely speed up the vaccine development process which typically takes years? In this lecture\, we will discuss how we can enable the immune system to fight serious infection. \nTime: 6:30-8:30 p.m.\, Wednesday\, December 2nd \nJoin us on: Zoom (password: Seminar) or YouTube Live \nSpeaker: Aly Warr \nGraphics: Iryna Stryapunina
URL:https://scienceinboston.com/event/hit-me-with-your-best-shot-vaccines-and-covid-19-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/COVID-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T160000
DTEND;TZID=America/Vancouver:20201202T180000
DTSTAMP:20260812T012800
CREATED:20201123T221533Z
LAST-MODIFIED:20201123T221533Z
UID:11833-1606924800-1606932000@scienceinboston.com
SUMMARY:MIT Alumni Virtual Research Slam
DESCRIPTION:Register to view and participate in an MIT Alumni Research Slam on December 2\, an online-only event celebrating alumni researchers hosted by the MIT Alumni Association. \nMIT alumni in research roles at colleges and universities will compete for $2\,000 in prizes* for best communicating their research to a panel of accomplished journalists and editors in a fast-paced virtual pitch competition. \nAttendees can join the fun too\, interacting with and learning from both aspiring and established researchers working on some of the world’s grand challenges. And live polling will contribute to an audience-choice award to complement the judges’ communications awards. \nJudges: \nAngus Chen\, Reporter\, WBUR CommonHealth \nGita Manaktala\, Editorial Director\, MIT Press \nYevgeniya Nusinovich ’01\, Senior Editor\, Science Magazine \nMC: Kirsty Bennett\, Manager\, MIT Women’s League and Founder\, MITell \nRegister now to:\n• Learn about new areas of research\n• Network and chat with fellow alumni\n• Polish your communication skills \nEvent Timeline\n4:00 p.m. Welcome and introductions\n4:15 p.m. Pitches begin\n5:30 p.m. Pitches end\, judges deliberate and name winners\n6:00 p.m. Event ends \nPrizes: \n1st Place: $1\,000 gift to MIT COVID-19 research made in competitor’s name\n2nd Place: $500 gift to MIT COVID-19 research made in competitor’s name\n3rd Place: $250 gift to MIT COVID-19 research made in competitor’s name \nInterested in competing? Email the organizers a short summary of your current research and affiliation. Eligible competitors must be degree-holding MIT alumni (of any discipline) who are current graduate students\, postdocs\, researchers\, or non-tenured faculty members at accredited colleges or universities around the world. All competitors will receive some of our favorite MIT swag and good publicity for their work!
URL:https://scienceinboston.com/event/mit-alumni-virtual-research-slam/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/research_slam_group_pic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T160000
DTEND;TZID=America/Vancouver:20201202T180000
DTSTAMP:20260812T012800
CREATED:20201123T221533Z
LAST-MODIFIED:20201123T221533Z
UID:27615-1606924800-1606932000@scienceinboston.com
SUMMARY:MIT Alumni Virtual Research Slam
DESCRIPTION:Register to view and participate in an MIT Alumni Research Slam on December 2\, an online-only event celebrating alumni researchers hosted by the MIT Alumni Association. \nMIT alumni in research roles at colleges and universities will compete for $2\,000 in prizes* for best communicating their research to a panel of accomplished journalists and editors in a fast-paced virtual pitch competition. \nAttendees can join the fun too\, interacting with and learning from both aspiring and established researchers working on some of the world’s grand challenges. And live polling will contribute to an audience-choice award to complement the judges’ communications awards. \nJudges: \nAngus Chen\, Reporter\, WBUR CommonHealth \nGita Manaktala\, Editorial Director\, MIT Press \nYevgeniya Nusinovich ’01\, Senior Editor\, Science Magazine \nMC: Kirsty Bennett\, Manager\, MIT Women’s League and Founder\, MITell \nRegister now to:\n• Learn about new areas of research\n• Network and chat with fellow alumni\n• Polish your communication skills \nEvent Timeline\n4:00 p.m. Welcome and introductions\n4:15 p.m. Pitches begin\n5:30 p.m. Pitches end\, judges deliberate and name winners\n6:00 p.m. Event ends \nPrizes: \n1st Place: $1\,000 gift to MIT COVID-19 research made in competitor’s name\n2nd Place: $500 gift to MIT COVID-19 research made in competitor’s name\n3rd Place: $250 gift to MIT COVID-19 research made in competitor’s name \nInterested in competing? Email the organizers a short summary of your current research and affiliation. Eligible competitors must be degree-holding MIT alumni (of any discipline) who are current graduate students\, postdocs\, researchers\, or non-tenured faculty members at accredited colleges or universities around the world. All competitors will receive some of our favorite MIT swag and good publicity for their work!
URL:https://scienceinboston.com/event/mit-alumni-virtual-research-slam-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/research_slam_group_pic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T160000
DTEND;TZID=America/Vancouver:20201202T173000
DTSTAMP:20260812T012800
CREATED:20201123T222314Z
LAST-MODIFIED:20201123T222314Z
UID:11842-1606924800-1606930200@scienceinboston.com
SUMMARY:Research on Tap: Wearables and Biosensors for Environmental and Human Health
DESCRIPTION:Hosted by Catherine Klapperich \nSensitive and more portable sensing platforms will allow us to quantify and predict how the world around us impacts human health and the environment. Monitoring the various chemicals and biomolecules around us and in our bodies is important in a wide range of disciplines including human development and disease\, epidemiology\, climate change\, food safety\, water management\, and many others. \nFor this Research on Tap\, we will bring together researchers from medicine\, public health\, engineering\, biology\, physics\, chemistry\, and environmental and data sciences to explore how new biosensing technologies and data analytics can drive new hypotheses and solutions for better health. \nFeaturing: Karen Allen | James Galagan | Christopher Gill | Matti Groll | Rebecca Khurshid | Yannis Paschalidis | Reza Rawassizadeh | Rob Reinhart | David Starobinski | Selim Ünlü
URL:https://scienceinboston.com/event/research-on-tap-wearables-and-biosensors-for-environmental-and-human-health/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T160000
DTEND;TZID=America/Vancouver:20201202T173000
DTSTAMP:20260812T012800
CREATED:20201123T222314Z
LAST-MODIFIED:20201123T222314Z
UID:27617-1606924800-1606930200@scienceinboston.com
SUMMARY:Research on Tap: Wearables and Biosensors for Environmental and Human Health
DESCRIPTION:Hosted by Catherine Klapperich \nSensitive and more portable sensing platforms will allow us to quantify and predict how the world around us impacts human health and the environment. Monitoring the various chemicals and biomolecules around us and in our bodies is important in a wide range of disciplines including human development and disease\, epidemiology\, climate change\, food safety\, water management\, and many others. \nFor this Research on Tap\, we will bring together researchers from medicine\, public health\, engineering\, biology\, physics\, chemistry\, and environmental and data sciences to explore how new biosensing technologies and data analytics can drive new hypotheses and solutions for better health. \nFeaturing: Karen Allen | James Galagan | Christopher Gill | Matti Groll | Rebecca Khurshid | Yannis Paschalidis | Reza Rawassizadeh | Rob Reinhart | David Starobinski | Selim Ünlü
URL:https://scienceinboston.com/event/research-on-tap-wearables-and-biosensors-for-environmental-and-human-health-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T070000
DTEND;TZID=America/Vancouver:20201204T160000
DTSTAMP:20260812T012800
CREATED:20201123T215713Z
LAST-MODIFIED:20201123T215713Z
UID:11817-1606892400-1607097600@scienceinboston.com
SUMMARY:2020 HMS Research Cores Online Poster Showcase
DESCRIPTION:Research Cores provide specialized services\, equipment\, and staff. Attend this event to learn about core technologies and resources at HMS.\n\n\n\n\n\nAbout this Event\n\n\nNote: Registration will remain open through noon on Dec. 4th. Register any time to attend the event. \nPoster Gallery opens Wednesday\, Dec. 2nd \nZoom meetings with Research Core Presenters: \nDecember 3rd\, 2020 \n10:30 – 11:30am ET \n12:30 – 1:30pm ET \n2:30 – 3:30pm ET \nDecember 4th\, 2020 \n10:30 – 11:30am ET \nFor the general schedule\, please visit the HMS cores website: https://corefacilities.hms.harvard.edu \nDetailed Zoom schedule information and meeting links will be emailed to registered Poster Showcase attendees.
URL:https://scienceinboston.com/event/2020-hms-research-cores-online-poster-showcase/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T070000
DTEND;TZID=America/Vancouver:20201204T160000
DTSTAMP:20260812T012800
CREATED:20201123T215713Z
LAST-MODIFIED:20201123T215713Z
UID:27610-1606892400-1607097600@scienceinboston.com
SUMMARY:2020 HMS Research Cores Online Poster Showcase
DESCRIPTION:Research Cores provide specialized services\, equipment\, and staff. Attend this event to learn about core technologies and resources at HMS.\n\n\n\n\n\nAbout this Event\n\n\nNote: Registration will remain open through noon on Dec. 4th. Register any time to attend the event. \nPoster Gallery opens Wednesday\, Dec. 2nd \nZoom meetings with Research Core Presenters: \nDecember 3rd\, 2020 \n10:30 – 11:30am ET \n12:30 – 1:30pm ET \n2:30 – 3:30pm ET \nDecember 4th\, 2020 \n10:30 – 11:30am ET \nFor the general schedule\, please visit the HMS cores website: https://corefacilities.hms.harvard.edu \nDetailed Zoom schedule information and meeting links will be emailed to registered Poster Showcase attendees.
URL:https://scienceinboston.com/event/2020-hms-research-cores-online-poster-showcase-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201201T160000
DTEND;TZID=America/Vancouver:20201201T170000
DTSTAMP:20260812T012800
CREATED:20201123T220936Z
LAST-MODIFIED:20201123T220950Z
UID:11823-1606838400-1606842000@scienceinboston.com
SUMMARY:MIT Biology Colloquium Series: Dr. Erin Schuman
DESCRIPTION:Speaker: Dr. Erin Schuman\, Max-Planck Institute. Title:” Neuronal Logistics: Transcriptomes\, Translatomes and Proteomes.”  Hosted by Elly Nedivi. The Biology Colloquium is a weekly seminar held throughout the academic year\, featuring distinguished speakers in many areas of the biological sciences\, from universities and institutions worldwide. More information on speakers\, their affiliations\, and titles of their talks will be added as available. The Colloquium will zoom at 4:00PM  Tuesdays during the school year. Contact: Linda Earle lkn@mit.edu
URL:https://scienceinboston.com/event/biology-colloquium-series-dr-erin-schuman/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201201T160000
DTEND;TZID=America/Vancouver:20201201T170000
DTSTAMP:20260812T012800
CREATED:20201123T220936Z
LAST-MODIFIED:20201123T220936Z
UID:27612-1606838400-1606842000@scienceinboston.com
SUMMARY:MIT Biology Colloquium Series: Dr. Erin Schuman
DESCRIPTION:Speaker: Dr. Erin Schuman\, Max-Planck Institute. Title:” Neuronal Logistics: Transcriptomes\, Translatomes and Proteomes.”  Hosted by Elly Nedivi. The Biology Colloquium is a weekly seminar held throughout the academic year\, featuring distinguished speakers in many areas of the biological sciences\, from universities and institutions worldwide. More information on speakers\, their affiliations\, and titles of their talks will be added as available. The Colloquium will zoom at 4:00PM  Tuesdays during the school year. Contact: Linda Earle lkn@mit.edu
URL:https://scienceinboston.com/event/biology-colloquium-series-dr-erin-schuman-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201201T110000
DTEND;TZID=America/Vancouver:20201201T113000
DTSTAMP:20260812T012800
CREATED:20201124T190122Z
LAST-MODIFIED:20201124T190122Z
UID:11854-1606820400-1606822200@scienceinboston.com
SUMMARY:MassBio Town Hall - 2021 Biotech Outlook
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a regular virtual Town Hall for members. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nThis Town Hall will feature Matthew Harrison\, a Managing Director and Head of Biotech Industry Research at Morgan Stanley\, who will share predictions for the biotech outlook in 2021. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. \nMassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-2021-biotech-outlook/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201201T110000
DTEND;TZID=America/Vancouver:20201201T113000
DTSTAMP:20260812T012800
CREATED:20201124T190122Z
LAST-MODIFIED:20201124T190122Z
UID:27618-1606820400-1606822200@scienceinboston.com
SUMMARY:MassBio Town Hall - 2021 Biotech Outlook
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a regular virtual Town Hall for members. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nThis Town Hall will feature Matthew Harrison\, a Managing Director and Head of Biotech Industry Research at Morgan Stanley\, who will share predictions for the biotech outlook in 2021. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. \nMassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-2021-biotech-outlook-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201119T120000
DTEND;TZID=America/Vancouver:20201119T130000
DTSTAMP:20260812T012800
CREATED:20201103T214500Z
LAST-MODIFIED:20201103T214500Z
UID:11466-1605787200-1605790800@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar: Dan Nomura
DESCRIPTION:Reimagining Druggability using Chemoproteomic Platforms\nWebinar registration: \nhttps://dfci.zoom.us/webinar/register/WN_IgnG5R2VSseCnikqf-v_1A \nHost: Breanna Zerfas \n\n\nDan Nomura\n\n\nDan Nomura is a professor in the Departments of Chemistry\, Molecular and Cell Biology\, and Nutritional Sciences and Toxicology at the University of California\, Berkeley. He is the director of the Novartis-Berkeley Center for Proteomics and Chemistry Technologies focused on using chemoproteomic platforms to tackle the undruggable proteome. Dr. Nomura is also the co-founder for Frontier Medicines. Dr. Nomura is an editor for Cell Chemical Biology. He earned his B.A. in Molecular and Cell Biology and Ph.D. in Molecular Toxicology with Professor John Casida at UC Berkeley and was a postdoctoral fellow at The Scripps Research Institute in chemical physiology with Professor Ben Cravatt before returning to UC Berkeley as a faculty member in 2011. Among his honors are selection as a Searle Scholar\, American Cancer Society Research Scholar Award\, and the Mark Foundation for Cancer Research ASPIRE Award.Research in the Nomura Research Group is focused on reimagining druggability using chemoproteomic platforms to discover new disease therapies. 
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-dan-nomura/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201119T120000
DTEND;TZID=America/Vancouver:20201119T130000
DTSTAMP:20260812T012800
CREATED:20201103T214500Z
LAST-MODIFIED:20201103T214500Z
UID:27605-1605787200-1605790800@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar: Dan Nomura
DESCRIPTION:Reimagining Druggability using Chemoproteomic Platforms\nWebinar registration: \nhttps://dfci.zoom.us/webinar/register/WN_IgnG5R2VSseCnikqf-v_1A \nHost: Breanna Zerfas \n\n\nDan Nomura\n\n\nDan Nomura is a professor in the Departments of Chemistry\, Molecular and Cell Biology\, and Nutritional Sciences and Toxicology at the University of California\, Berkeley. He is the director of the Novartis-Berkeley Center for Proteomics and Chemistry Technologies focused on using chemoproteomic platforms to tackle the undruggable proteome. Dr. Nomura is also the co-founder for Frontier Medicines. Dr. Nomura is an editor for Cell Chemical Biology. He earned his B.A. in Molecular and Cell Biology and Ph.D. in Molecular Toxicology with Professor John Casida at UC Berkeley and was a postdoctoral fellow at The Scripps Research Institute in chemical physiology with Professor Ben Cravatt before returning to UC Berkeley as a faculty member in 2011. Among his honors are selection as a Searle Scholar\, American Cancer Society Research Scholar Award\, and the Mark Foundation for Cancer Research ASPIRE Award.Research in the Nomura Research Group is focused on reimagining druggability using chemoproteomic platforms to discover new disease therapies. 
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-dan-nomura-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T160000
DTEND;TZID=America/Vancouver:20201118T173000
DTSTAMP:20260812T012800
CREATED:20201022T210520Z
LAST-MODIFIED:20201022T210520Z
UID:11264-1605715200-1605720600@scienceinboston.com
SUMMARY:BU Research on Tap: Diverse Approaches to Understanding and Controlling COVID-19
DESCRIPTION:The COVID-19 pandemic erupted with unprecedented speed. There remains much we do not understand about COVID-19 and the pathogen responsible for causing it\, the novel coronavirus now known as SARS-CoV-2. Although this virus was initially thought to be solely respiratory\, we now know it is capable of causing a more widespread disease. Given the urgency to understand this pathogen and the disease it causes\, BU scientists from a variety of disciplines turned their attention to developing tools to understand the virus and its impact on the cell it infects\, identifying therapies to interfere with the viral life cycle\, developing models to study the disease process\, and developing novel means to detect and inactivate the virus. This session is intended to provide insights into the diverse challenges the SARS-CoV-2 virus presents\, and how BU scientists are responding to help control it.
URL:https://scienceinboston.com/event/bu-research-on-tap-diverse-approaches-to-understanding-and-controlling-covid-19/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T160000
DTEND;TZID=America/Vancouver:20201118T173000
DTSTAMP:20260812T012800
CREATED:20201022T210520Z
LAST-MODIFIED:20201022T210520Z
UID:27601-1605715200-1605720600@scienceinboston.com
SUMMARY:BU Research on Tap: Diverse Approaches to Understanding and Controlling COVID-19
DESCRIPTION:The COVID-19 pandemic erupted with unprecedented speed. There remains much we do not understand about COVID-19 and the pathogen responsible for causing it\, the novel coronavirus now known as SARS-CoV-2. Although this virus was initially thought to be solely respiratory\, we now know it is capable of causing a more widespread disease. Given the urgency to understand this pathogen and the disease it causes\, BU scientists from a variety of disciplines turned their attention to developing tools to understand the virus and its impact on the cell it infects\, identifying therapies to interfere with the viral life cycle\, developing models to study the disease process\, and developing novel means to detect and inactivate the virus. This session is intended to provide insights into the diverse challenges the SARS-CoV-2 virus presents\, and how BU scientists are responding to help control it.
URL:https://scienceinboston.com/event/bu-research-on-tap-diverse-approaches-to-understanding-and-controlling-covid-19-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T120000
DTEND;TZID=America/Vancouver:20201118T130000
DTSTAMP:20260812T012800
CREATED:20201030T155201Z
LAST-MODIFIED:20201030T155201Z
UID:11408-1605700800-1605704400@scienceinboston.com
SUMMARY:Webinar: Investigating Cellular Pathways Driving Severe COVID-19: Fresh Insights from Longitudinal Plasma Proteomics
DESCRIPTION:COVID-19 has caused more than 1 million deaths worldwide. Extraordinary research efforts are being made at the lab bench and in the clinic\, aided by initiatives such as diverted funding\, accelerated publication channels\, increased collaboration\, and open sharing of data. In order to accelerate research into the pandemic\, the “COVID-19 Technology Access Framework” was set up by Harvard University\, the Massachusetts Institute of Technology\, and Stanford University\, to pool resources and ensure that research findings and data are shared rapidly and openly to inform the public health response. Within this framework\, researchers from Massachusetts General Hospital recently collaborated with Olink Proteomics to carry out one of the largest longitudinal COVID-19 studies to date. This study aimed to generate new insights into the mechanisms underlying immune responses and disease severity in infected patients by serial measurements of over 1\,400 proteins in a cohort of ~400 SARS-CoV-2–infected patients and symptomatic controls. Hundreds of plasma proteins were found to be differentially expressed between COVID-19 patients and controls\, as well as between those with mild and severe forms of the disease. Together with cellular and RNA expression analyses\, the study also enabled a detailed dissection of both systemic and tissue-specific responses to SARS-CoV-2. This rich dataset of over 1.3 million protein measurements and essential clinical data has been made freely available to the scientific community to facilitate further investigation of pathways underlying severe disease—which may be the basis for early diagnosis of COVID-19 and subsequent clinical intervention. \nDuring the webinar\, viewers will: \n\nLearn how the levels of over 600 plasma proteins differ between infected patients and controls\, with a “viral response signature” of multiple cytokines and other proteins identified\nDiscover that more than 200 proteins also discriminate between severe and non-severe COVID-19\, and that specific proteins are associated with survival or death in those with severe disease\nHear about the differential molecular and cellular immune responses to SARS-CoV-2 infection at the tissue and systemic level\, and gain new insights into tissue-specific cell death signatures and cell-to-cell communication\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes. \nSpeaker bios\n\nMichael Filbin\, M.D.\, M.Sc.\n\nMassachusetts General Hospital\nBoston\, MA \n\nDr. Filbin is an emergency physician and director of clinical research in the Department of Emergency Medicine at Massachusetts General Hospital (MGH) in Boston and an associated member of the Broad Institute of MIT and Harvard. His research involves early detection and management of septic shock. Over the past decade\, Dr. Filbin has been a key investigator in U.S. National Institutes of Health–funded multicenter clinical trials\, led sepsis quality improvement efforts\, and investigated early sepsis detection strategies. He cochairs the Sepsis Early Detection Think Tank at MGH with the mission of joining translational researchers and clinical investigators within the Harvard community to encourage novel diagnostic and therapeutic approaches in sepsis. Dr. Filbin received a bachelor’s degree in aeronautics and aerospace engineering from the University of Washington in Seattle. He embarked on a career in engineering at the National Aeronautics and Space Administration in Houston\, Texas\, before attending medical school at Baylor College of Medicine in Houston. He completed a residency in emergency medicine at the combined Harvard Affiliated Emergency Medicine Residency program and received a Master’s in clinical epidemiology from the Harvard School of Public Health in Boston. \n\n\n\n\nArnav Mehta\, M.D.\, Ph.D.\n\nBroad Institute of MIT and Harvard\nBoston\, MA \n\nDr. Mehta is an oncologist\, immunologist\, and mathematician who is currently a postdoctoral researcher in Nir Hacohen and Eric Lander’s labs at the Broad Institute of MIT and Harvard\, and a clinical fellow in hematology/oncology at the Dana-Farber Cancer Institute/Partners CancerCare. Prior to his current position\, he obtained his undergraduate degrees at Duke University studying mathematics and chemistry\, his M.D. at the David Geffen School of Medicine at the University of California\, Los Angeles\, and his Ph.D. in biology and bioengineering at the California Institute of Technology under the guidance of Nobel laureate David Baltimore. He completed his internal medicine residency at Massachusetts General Hospital in the Stanbury Physician-Scientist Pathway program. His current interests lie at the intersection of tumor immunology and computational biology\, with a focus on building new tools for single-cell genomics studies in tumors. \n\n\n\n\nSean Sanders\, Ph.D.\n\nScience/AAAS\nWashington\, DC \n\nDr. Sanders did his undergraduate training at the University of Cape Town\, South Africa\, and his Ph.D. at the University of Cambridge\, UK\, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University\, Dr. Sanders joined TranXenoGen\, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing\, Dr. Sanders joined BioTechniques as an editor\, before joining Science/AAAS in 2006. Currently\, Dr. Sanders is the Director and Senior Editor for Custom Publishing for the journal Science and Program Director for Outreach.
URL:https://scienceinboston.com/event/webinar-investigating-cellular-pathways-driving-severe-covid-19-fresh-insights-from-longitudinal-plasma-proteomics/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/ElAnxPUXgAEQXuJ.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T120000
DTEND;TZID=America/Vancouver:20201118T130000
DTSTAMP:20260812T012800
CREATED:20201030T155201Z
LAST-MODIFIED:20201030T155201Z
UID:27602-1605700800-1605704400@scienceinboston.com
SUMMARY:Webinar: Investigating Cellular Pathways Driving Severe COVID-19: Fresh Insights from Longitudinal Plasma Proteomics
DESCRIPTION:COVID-19 has caused more than 1 million deaths worldwide. Extraordinary research efforts are being made at the lab bench and in the clinic\, aided by initiatives such as diverted funding\, accelerated publication channels\, increased collaboration\, and open sharing of data. In order to accelerate research into the pandemic\, the “COVID-19 Technology Access Framework” was set up by Harvard University\, the Massachusetts Institute of Technology\, and Stanford University\, to pool resources and ensure that research findings and data are shared rapidly and openly to inform the public health response. Within this framework\, researchers from Massachusetts General Hospital recently collaborated with Olink Proteomics to carry out one of the largest longitudinal COVID-19 studies to date. This study aimed to generate new insights into the mechanisms underlying immune responses and disease severity in infected patients by serial measurements of over 1\,400 proteins in a cohort of ~400 SARS-CoV-2–infected patients and symptomatic controls. Hundreds of plasma proteins were found to be differentially expressed between COVID-19 patients and controls\, as well as between those with mild and severe forms of the disease. Together with cellular and RNA expression analyses\, the study also enabled a detailed dissection of both systemic and tissue-specific responses to SARS-CoV-2. This rich dataset of over 1.3 million protein measurements and essential clinical data has been made freely available to the scientific community to facilitate further investigation of pathways underlying severe disease—which may be the basis for early diagnosis of COVID-19 and subsequent clinical intervention. \nDuring the webinar\, viewers will: \n\nLearn how the levels of over 600 plasma proteins differ between infected patients and controls\, with a “viral response signature” of multiple cytokines and other proteins identified\nDiscover that more than 200 proteins also discriminate between severe and non-severe COVID-19\, and that specific proteins are associated with survival or death in those with severe disease\nHear about the differential molecular and cellular immune responses to SARS-CoV-2 infection at the tissue and systemic level\, and gain new insights into tissue-specific cell death signatures and cell-to-cell communication\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes. \nSpeaker bios\n\nMichael Filbin\, M.D.\, M.Sc.\n\nMassachusetts General Hospital\nBoston\, MA \n\nDr. Filbin is an emergency physician and director of clinical research in the Department of Emergency Medicine at Massachusetts General Hospital (MGH) in Boston and an associated member of the Broad Institute of MIT and Harvard. His research involves early detection and management of septic shock. Over the past decade\, Dr. Filbin has been a key investigator in U.S. National Institutes of Health–funded multicenter clinical trials\, led sepsis quality improvement efforts\, and investigated early sepsis detection strategies. He cochairs the Sepsis Early Detection Think Tank at MGH with the mission of joining translational researchers and clinical investigators within the Harvard community to encourage novel diagnostic and therapeutic approaches in sepsis. Dr. Filbin received a bachelor’s degree in aeronautics and aerospace engineering from the University of Washington in Seattle. He embarked on a career in engineering at the National Aeronautics and Space Administration in Houston\, Texas\, before attending medical school at Baylor College of Medicine in Houston. He completed a residency in emergency medicine at the combined Harvard Affiliated Emergency Medicine Residency program and received a Master’s in clinical epidemiology from the Harvard School of Public Health in Boston. \n\n\n\n\nArnav Mehta\, M.D.\, Ph.D.\n\nBroad Institute of MIT and Harvard\nBoston\, MA \n\nDr. Mehta is an oncologist\, immunologist\, and mathematician who is currently a postdoctoral researcher in Nir Hacohen and Eric Lander’s labs at the Broad Institute of MIT and Harvard\, and a clinical fellow in hematology/oncology at the Dana-Farber Cancer Institute/Partners CancerCare. Prior to his current position\, he obtained his undergraduate degrees at Duke University studying mathematics and chemistry\, his M.D. at the David Geffen School of Medicine at the University of California\, Los Angeles\, and his Ph.D. in biology and bioengineering at the California Institute of Technology under the guidance of Nobel laureate David Baltimore. He completed his internal medicine residency at Massachusetts General Hospital in the Stanbury Physician-Scientist Pathway program. His current interests lie at the intersection of tumor immunology and computational biology\, with a focus on building new tools for single-cell genomics studies in tumors. \n\n\n\n\nSean Sanders\, Ph.D.\n\nScience/AAAS\nWashington\, DC \n\nDr. Sanders did his undergraduate training at the University of Cape Town\, South Africa\, and his Ph.D. at the University of Cambridge\, UK\, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University\, Dr. Sanders joined TranXenoGen\, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing\, Dr. Sanders joined BioTechniques as an editor\, before joining Science/AAAS in 2006. Currently\, Dr. Sanders is the Director and Senior Editor for Custom Publishing for the journal Science and Program Director for Outreach.
URL:https://scienceinboston.com/event/webinar-investigating-cellular-pathways-driving-severe-covid-19-fresh-insights-from-longitudinal-plasma-proteomics-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/ElAnxPUXgAEQXuJ.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T100000
DTEND;TZID=America/Vancouver:20201118T160000
DTSTAMP:20260812T012800
CREATED:20201022T205608Z
LAST-MODIFIED:20201022T205608Z
UID:11259-1605693600-1605715200@scienceinboston.com
SUMMARY:MIT Neurotech 2020
DESCRIPTION:The Neurotech 2020 symposium presents virtual talks by neurotechnology pioneers whose cutting-edge innovations are changing the face of neurobiological research from molecules to cognition. The symposium is open to the public\, but registration is required.  This year’s speakers are Todd Coleman (UCSD)\, Guosong Hong (Stanford University)\, Xin Jin (Harvard University & Broad Institute)\, Nancy Kopell (Boston University)\, Rosalind Picard (MIT)\, and Mikhail Shapiro (Caltech).  Talk schedule and registration link to follow soon.
URL:https://scienceinboston.com/event/mit-neurotech-2020/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/MIT-Neurotech-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T100000
DTEND;TZID=America/Vancouver:20201118T160000
DTSTAMP:20260812T012800
CREATED:20201022T205608Z
LAST-MODIFIED:20201022T205608Z
UID:27600-1605693600-1605715200@scienceinboston.com
SUMMARY:MIT Neurotech 2020
DESCRIPTION:The Neurotech 2020 symposium presents virtual talks by neurotechnology pioneers whose cutting-edge innovations are changing the face of neurobiological research from molecules to cognition. The symposium is open to the public\, but registration is required.  This year’s speakers are Todd Coleman (UCSD)\, Guosong Hong (Stanford University)\, Xin Jin (Harvard University & Broad Institute)\, Nancy Kopell (Boston University)\, Rosalind Picard (MIT)\, and Mikhail Shapiro (Caltech).  Talk schedule and registration link to follow soon.
URL:https://scienceinboston.com/event/mit-neurotech-2020-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/MIT-Neurotech-2020.jpg
END:VEVENT
END:VCALENDAR